The Clinical and Financial Burden of Preemptive Management of CMV Disease after Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches

BACKGROUND: Although CMV infection after allogeneic stem cell transplantation (SCT) is only rarely fatal, the management of CMV by preemptive medication for viral reactivation has toxicity and carries a financial burden. New strategies to prevent CMV reactivation with vaccines and antiviral T cells...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jain, Natasha A., Lu, Kit, Ito, Sawa, Muranski, Pawel, Hourigan, Christopher S., Haggerty, Janice, Chokshi, Puja D., Ramos, Catalina, Cho, Elena, Cook, Lisa, Childs, Richard, Battiwalla, Minoo, Barrett, A. John
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4051841/
https://ncbi.nlm.nih.gov/pubmed/24831837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2014.02.010
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados